US survey - Financial reporting leaders' AI expectations for their companies and auditors in the Healthcare and Life Sciences industry.
100% of US financial reporting leaders surveyed report they expect to be using artificial intelligence (AI) in financial reporting within three years (up from 71% today), and 97% expect to be using generative AI (GenAI) (up from 46% today), according to the survey report, AI in Financial Reporting and Audit: Navigating the New Era. The global survey was conducted among 1,800 companies across ten major markets, including Healthcare and Life Sciences.
More detailed US findings are available in the full report.
AI in financial reporting and audit: Navigating the new era
US Survey Results: Healthcare and Life Sciences
Download PDFUnlocking the value of Real-World Data in the era of Gen AI
How to capitalize on this dynamic opportunity for healthcare and life sciences at the intersection of RWD and GenAI.
The importance of Trusted AI in healthcare
Crafting the future of healthcare’s relationship with technology
2024 Healthcare and Life Sciences Investment Outlook
We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.
Healthcare and life sciences M&A: Poised for a rebound?
After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.
GenAI is poised to transform healthcare. Is healthcare ready?
The fast-moving tech’s revolutionary potential promises to redefine a massive industry and its slow-mover history—and the stakes have never been higher.